Therapeutic efficacy of complex treatment of cows with catarrhal mastitis

Abstract

Mastitis in cows is widespread and causes great economic damage to agriculture. Every year, according to domestic and foreign authors, from 20 to 50% of highly productive cows get sick with mastitis during lactation. Mastitis milk leads to changes in the chemical composition of combined milk, as a result of which biochemical and microbiological processes are disturbed during its processing. The milk obtained from cows with mastitis does not coagulate well with rennet, is less thermosensitive, and productively valuable lactic acid bacteria do not develop in it. The damage caused by mastitis consists of a decrease in milk productivity, premature culling of animals, deterioration in the technological properties of milk, as well as the cost of diagnosis and treatment. The work was carried out in the livestock complex KH Agrofirm "Chokh" of the Gunibsky district of Dagestan Republic, on cows of the red steppe breed, aged from three to seven years, with mastitis, in the amount of 85 heads, divided into three groups: two experimental – 30 heads and one control – 25. The cows of the first experimental group were “intracisternally injected with the drug Laktiko, one syringe dispenser - 3 ml, in combination with the vitamin complex - Activiton, at a dose of 20 ml per head, for 3-4 days, the second - Gamaret, at a dose of 10 ml (1 syringe - dispenser), in combination with a probiotic - Gamavit, to control cows - Mastisan A, at a dose of 10 ml, once a day.The developed complex scheme for the treatment of catarrhal mastitis using the drug Laktiko in combination with Activiton, has a therapeutic efficacy 96.6%, the biochemical parameters in the first experimental group correspond to the “physiological norm on the 3rd day of treatment, the restoration of the productivity of the treated shares to 60 is day – 95%.